Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

How to speed up development: share work with rivals, say scientists

Early stage delays are creating a development 'bottleneck', say Georgia Institute of Technology researchers.

Drug developers should add their early-stage discoveries to an open-source database or pay a fine to cut wasted time duplicating results, say researchers.

Related news

News in brief

News of the discontinuation of the National Cancer Institute’s (NCI) Animal Production Program has led Charles River Laboratories rival Harlan to vie for the market of grantees that still need animal research models.

Clinverse, a provider of automated financial management tech solutions for clinical trials, has closed a $9.1m (€6.9m) round of funding led by New Jersey-based Edison Partners.

We cover the latest changes in outsourcing, including the future star players of pharma philanthropy. 

A 3D printed human liver system could offer better informed risk-based decisions earlier in the drug development process than with current in vitro models, according to developers Organovo.

Global Industry News

GSK welcomes US OK for Arnuity in light of declining Advair sales from

US FDA approval of the inhaled corticosteroid (ICS) asthma drug Arnuity will help offset declining sales of the off-patent bestseller Advair, says GlaxoSmithKline.

Ben Venue site has no place in injectables network, says new owner Hikma from

Ben Venue Laboratories will remain inactive says new owner Hikma as it looks to optimise its injectables manufacturing network.

Macfarlan Smith fined $12,000 after accident at API plant from

Opiate API manufacturer Macfarlan Smith has been fined £12,000 for failing to ensure the safety of an employee injured at its plant in Scotland in 2011.

Eisai sues FDA for ‘losing one year’ of marketing to generics rivals from

Eisai has accused the US FDA of unlawfully shortening market exclusivity periods for Belviq and Fycompa by starting the countdown one year before either was scheduled by the DEA.

Cell line development set to get faster says Horizon Discovery from

CRISPR gene editing will make cell line development cheaper and faster according to Horizon Discovery, which says that new tech has application in both biomanufacturing and preclinical disease modelling.

G-CON's containment PODs launched in response to Ebola crisis from

G-CON has responded to the ongoing Ebola virus outbreak in West Africa by retooling its “vaccine facility in a box” PODs as patient isolation units to help stop the spread of the disease.

Frogs, fungus and falsified data - Indian firm falls foul of US FDA from

Indian drugmaker Amanta has received a warning letter after the US FDA found evidence of data falsification and unsanitary conditions – including dead and decaying frogs next to a product exit dock – during an inspection last year.

India changes course, calls for bar codes for mono cartons in April from

Nearly a month after India pushed back its deadline indefinitely  for exporters to put bar codes on their primary packages, the Directorate General of Foreign Trade  (DGFT) has set a new deadline of April 2015.